BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majewska A, Mlynarczyk-Bonikowska B. 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs? Int J Mol Sci 2022;23:3431. [PMID: 35408788 DOI: 10.3390/ijms23073431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hassan STS, Šudomová M, Mazurakova A, Kubatka P. Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses. IJMS 2022;23:13891. [DOI: 10.3390/ijms232213891] [Reference Citation Analysis]
2 Kotton BD, Kotton CN. Resistant herpes simplex virus infections - who, when, and what's new? Curr Opin Infect Dis 2022. [PMID: 36206151 DOI: 10.1097/QCO.0000000000000889] [Reference Citation Analysis]
3 Zannella C, Chianese A, De Bernardo M, Folliero V, Petrillo F, De Filippis A, Boccia G, Franci G, Rosa N, Galdiero M. Ophthalmic Solutions with a Broad Antiviral Action: Evaluation of Their Potential against Ocular Herpetic Infections. Microorganisms 2022;10:1728. [DOI: 10.3390/microorganisms10091728] [Reference Citation Analysis]